Pharmacological Preparation of the Cervix for Hysteroscopy
NCT ID: NCT05783479
Last Updated: 2023-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2022-06-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Paracervical Block During Office Hysteroscopy
NCT00811187
The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation
NCT06316180
Clinical Efficacy of Virtual Reality During Office Hysteroscopy and Endometrial Biopsy in Subfertility
NCT04438759
Women With Asymptomatic Endometrial Hyperplasia
NCT02100137
Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI
NCT03784404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 (estradiol)
estradiol 0.5 mg in vaginal cream twice daily for 10 days pre-procedure
estradiol
estradiol 0.5 mg in vaginal cream twice daily for 10 days pre-procedure
2 (hyaluronic acid)
hyaluronic acid 5 mg in vaginal gel twice daily for 10 days pre-procedure
Hyaluronic acid
hyaluronic acid 5 mg in vaginal gel twice daily for 10 days pre-procedure
3 (control)
no preparation of the cervix - arm without medication
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
estradiol
estradiol 0.5 mg in vaginal cream twice daily for 10 days pre-procedure
Hyaluronic acid
hyaluronic acid 5 mg in vaginal gel twice daily for 10 days pre-procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* uterine cavity focal lesion, abnormal uterine bleeding
Exclusion Criteria
* no consent to the procedure or participation in the study
45 Years
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iwona Magdalena Gawron
Ph.D., Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Jach, Prof.
Role: STUDY_CHAIR
Jagiellonian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jagiellonian University Medical College, Department of Gynecology and Obstetrics
Krakow, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.128.2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.